Skip to main content

Table 3 Summary of the GRADE quality of evidence assessment

From: Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis

Quality Assessment

Number of Patients

SMD

(95% CI)

Quality

# Studies

Risk of Bias

Inconsistency

Indirectness

Imprecision

Publication Bias

DM

Control

DM vs. Healthy Controls

13

Not serious

Serious

Not serious

Not serious

Not serious

888

751

1.00

[0.81, 1.19]

⊕⊕⊕Ο

Moderate†

DM without other comorbidities vs. Healthy Controls

9

Not serious

Serious

Not serious

Not serious

Not serious

705

458

1.03

[0.79, 1.28]

⊕⊕⊕Ο

Moderate†

T2DM vs. Healthy Controls

10

Not serious

Serious

Not serious

Not serious

Not serious

641

394

1.01

[0.20, 1.67]

⊕⊕⊕Ο

Moderate†

T2DM without other comorbidities vs. Healthy Controls

8

Not serious

Serious

Not serious

Not serious

Not serious

805

590

1.02

[0.74, 1.31]

⊕⊕⊕Ο

Moderate†

  1. Abbreviations: CI: confidence interval, SMD: Standardized Mean Difference
  2. †Moderate due to serious inconsistencies and high heterogeneity in meta-analysis